In lung cancer, circRABL2B interacts with YBX1 to suppress MUC5AC, which in turn inhibits integrin β4/pSrc/p53 signaling as well as tumor stem cell characteristics, thereby augmenting erlotinib sensitivity.716 Additionally, circRNAs can influence targeted therapy sensitivity by binding to proteins. The gene discussed is YBX1; the disease is neoplasm.